Oxysterols: An emerging class of broad spectrum antiviral effectors

Molecular Aspects of Medicine

Volumn 49, Issue , 2016, Pages 23-30

  Lembo, David ^a   Cagno, Valeria ^a   Civra, Andrea ^a   Poli, Giuseppe ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

25 Hydroxycholesterol; 27 Hydroxycholesterol; Antiviral; Enveloped virus; Innate immunity; Non enveloped viruses; Oxysterols

Indexed keywords

20ALPHA HYDROXYCHOLESTEROL; 22 HYDROXYCHOLESTEROL; 24 HYDROXYCHOLESTEROL; 25 HYDROXYCHOLESTEROL; 7 BETA 25 HYDROXYCHOLESTEROL; 7 BETA HYDROXYCHOLESTEROL; ANTIVIRUS AGENT; NONSTRUCTURAL PROTEIN 5A; OXYSTEROL; OXYSTEROL BINDING PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; UNCLASSIFIED DRUG; REACTIVE OXYGEN METABOLITE;

ANTIVIRAL ACTIVITY; DRUG METABOLISM; EBOLAVIRUS; EC50; ENVELOPED VIRUS; GOLGI MEMBRANE; HERPES SIMPLEX VIRUS 1; HERPESVIRIDAE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE RESPONSE; IN VITRO STUDY; INFLUENZA A VIRUS (H1N1); INNATE IMMUNITY; LIPID MEMBRANE; LIPID METABOLISM; MURID HERPESVIRUS 68; MURINE GAMMA HERPES VIRUS 68; NIPAH VIRUS; NONHUMAN; PICORNAVIRIDAE; POLIOMYELITIS VIRUS; PSEUDOVIRUS; REVIEW; RHINOVIRUS; RIFT VALLEY FEVER VIRUS; TRANSCRIPTION INITIATION; VARICELLA ZOSTER VIRUS; VESCICULAR STOMATITIS VIRUS; VIRUS; VIRUS ENVELOPE; VIRUS INHIBITION; VIRUS PARTICLE; ANIMAL; CHEMISTRY; DRUG EFFECTS; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; OXIDATION REDUCTION REACTION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; OXIDATION-REDUCTION; OXYSTEROLS; REACTIVE OXYGEN SPECIES; VIRUS REPLICATION; VIRUSES;

EID: 84963805036     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2016.04.003     Document Type: Review

References (44)

1. V. Agnello, G. Abel, M. Elfahal, G.B. Knight, and Zhang Q.X. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor Proc. Natl. Acad. Sci. U.S.A. 96 1999 12766 12771
2. Anggakusuma, I. Romero-Brey, C. Berger, C.C. Colpitts, T. Boldanova, M. Engelmann, and et al. Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation Hepatology 62 2015 702 714
3. M. Arita, H. Kojima, T. Nagano, T. Okabe, T. Wakita, and H. Shimizu Oxysterol-binding protein family I is the target of minor enviroxime-like compounds J. Virol 87 2013 4252 4260
4. C.T. Beh, L. Cool, J. Phillips, and J. Rine Overlapping functions of the yeast oxysterol-binding protein homologues Genetics 157 2001 1117 1140
5. S.J. Bensinger, and P. Tontonoz Integration of metabolism and inflammation by lipid-activated nuclear receptors Nature 454 2008 470 477
6. M. Blanc, W.Y. Hsieh, K.A. Robertson, K.A. Kropp, T. Forster, Shui G., and et al. The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response Immunity 38 2013 106 118
7. Chen Y., Wang S., Yi Z., Tian H., R. Aliyari, Li Y., and et al. Interferon-inducible cholesterol-25-hydroxylase inhibits hepatitis C virus replication via distinct mechanisms Sci. Rep 4 2014 7242
8. A. Civra, V. Cagno, M. Donalisio, F. Biasi, G. Leonarduzzi, G. Poli, and et al. Inhibition of pathogenic non-enveloped viruses by 25-hydroxycholesterol and 27-hydroxycholesterol Sci. Rep 4 2014 7487
9. C.M. Dorobantu, L. Albulescu, C. Harak, Feng Q., M. van Kampen, J.R. Strating, and et al. Modulation of the host lipid landscape to promote RNA virus replication: the picornavirus encephalomyocarditis virus converges on the pathway used by hepatitis C virus PLoS Pathog 11 2015 e1005185
10. S.E. Gale, E.J. Westover, N. Dudley, K. Krishnan, S. Merlin, D.E. Scherrer, and et al. Side chain oxygenated cholesterol regulates cellular cholesterol homeostasis through direct sterol-membrane interactions J. Biol. Chem 284 2009 1755 1764
11. E.S. Gold, A.H. Diercks, I. Podolsky, R.L. Podyminogin, P.S. Askovich, P.M. Treuting, and et al. 25-Hydroxycholesterol acts as an amplifier of inflammatory signaling Proc. Natl. Acad. Sci. U.S.A. 111 2014 10666 10671
12. J.L. Goldstein, R.A. DeBose-Boyd, and M.S. Brown Protein sensors for membrane sterols Cell 124 2006 35 46
13. N.Y. Hsu, O. Ilnytska, G. Belov, M. Santiana, Chen Y.H., P.M. Takvorian, and et al. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication Cell 141 2010 799 811
14. Huang H., Sun F., D.M. Owen, Li W., Chen Y., M. Gale Jr., and et al. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins Proc. Natl. Acad. Sci. U.S.A. 104 2007 5848 5853
15. M. Iwamoto, K. Watashi, S. Tsukuda, H.H. Aly, M. Fukasawa, A. Fujimoto, and et al. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP Biochem. Biophys. Res. Commun 443 2014 808 813
16. B.A. Janowski, M.J. Grogan, S.A. Jones, G.B. Wisely, S.A. Kliewer, E.J. Corey, and et al. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta Proc. Natl. Acad. Sci. U.S.A. 96 1999 266 271
17. Y. Lange, Ye J., and F. Strebel Movement of 25-hydroxycholesterol from the plasma membrane to the rough endoplasmic reticulum in cultured hepatoma cells J. Lipid Res 36 1995 1092 1097
18. M. Lehto, S. Laitinen, G. Chinetti, M. Johansson, C. Ehnholm, B. Staels, and et al. The OSBP-related protein family in humans J. Lipid Res 42 2001 1203 1213
19. G. Leonarduzzi, B. Sottero, and G. Poli Oxidized products of cholesterol: dietary and metabolic origin, and proatherosclerotic effects J. Nutr. Biochem 13 2002 700 710
20. G. Leonarduzzi, P. Gamba, B. Sottero, A. Kadl, F. Robbesyn, R.A. Calogero, and et al. Oxysterol-induced up-regulation of MCP-1 expression and synthesis in macrophage cells Free Radic. Biol. Med 39 2005 1152 1161
21. Li Q., V. Pène, S. Krishnamurthy, H. Cha, and Liang T.J. Hepatitis C virus infection activates an innate pathway involving IKK-α in lipogenesis and viral assembly Nat. Med 19 2013 722 729
22. Liu S.Y., R. Aliyari, K. Chikere, Li G., M.D. Marsden, J.K. Smith, and et al. Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol Immunity 38 2013 92 105
23. Y. Miyanari, K. Atsuzawa, N. Usuda, K. Watashi, T. Hishiki, M. Zayas, and et al. The lipid droplet is an important organelle for hepatitis C virus production Nat. Cell Biol 9 2007 1089 1097 Erratum in: Nat Cell Biol 2007 9, 1216
24. S. Molina, V. Castet, C. Fournier-Wirth, L. Pichard-Garcia, R. Avner, D. Harats, and et al. The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus J. Hepatol 46 2007 411 419
25. C. Moog, A.M. Aubertin, A. Kirn, and B. Luu Oxysterols, but not cholesterol, inhibit human immunodeficiency virus replication in vitro Antivir. Chem. Chemother 9 1998 491 496
26. J.K. Oem, C. Jackel-Cram, Li Y.P., Zhou Y., Zhong J., H. Shimano, and et al. Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus non-structural protein 2 J. Gen. Virol 89 2008 1225 1230
27. V.M. Olkkonen, and Li S. Oxysterol-binding proteins: sterol and phosphoinositide sensors coordinating transport, signaling and metabolism Prog. Lipid Res 52 2013 529 538
28. A.D. Olmstead, W. Knecht, I. Lazarov, S.B. Dixit, and F. Jean Human subtilase SKI-1/S1P is a master regulator of the HCV Lifecycle and a potential host cell target for developing indirect-acting antiviral agents PLoS Pathog 8 1 2012 e1002468
29. B.N. Olsen, P.H. Schlesinger, D.S. Ory, and N.A. Baker 25-Hydroxycholesterol increases the availability of cholesterol in phospholipid membranes Biophys. J. 100 2011 948 956
30. J.P. Pezacki, S.M. Sagan, A.M. Tonary, Y. Rouleau, S. Bélanger, L. Supekova, and et al. Transcriptional profiling of the effects of 25-hydroxycholesterol on human hepatocyte metabolism and the antiviral state it conveys against the hepatitis C virus BMC Chem. Biol 9 2009 2
31. F. Ramalho Hepatitis C virus infection and liver steatosis Antiviral Res 60 2003 125 127
32. P.S. Roulin, M. Lötzerich, F. Torta, L.B. Tanner, F.J. van Kuppeveld, M.R. Wenk, and et al. Rhinovirus uses a phosphatidylinositol 4-phosphate/cholesterol counter-current for the formation of replication compartments at the ER-Golgi interface Cell Host Microbe 16 2014 677 690
33. S.M. Sagan, Y. Rouleau, C. Leggiadro, L. Supekova, P.G. Schultz, Su A.I., and et al. The influence of cholesterol and lipid metabolism on host cell structure and hepatitis C virus replication Biochem. Cell Biol 84 2006 67 79
34. E. Scarselli, H. Ansuini, R. Cerino, R.M. Roccasecca, S. Acali, G. Filocamo, and et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus EMBO J. 21 2002 5017 5025
35. G.J. Schroepfer Jr. Oxysterols: modulators of cholesterol metabolism and other processes Physiol. Rev 80 2000 361 554
36. R. Singaravelu, S. O'Hara, D.M. Jones, Chen R., N.G. Taylor, P. Srinivasan, and et al. MicroRNAs regulate the immunometabolic response to viral infection in the liver Nat. Chem. Biol 11 2015 988 993
37. Su A.I., J.P. Pezacki, L. Wodicka, A.D. Brideau, L. Supekova, R. Thimme, and et al. Genomic analysis of the host response to hepatitis C virus infection Proc. Natl. Acad. Sci. U.S.A. 99 2002 15669 15674
38. F.R. Taylor, S.E. Saucier, E.P. Shown, E.J. Parish, and A.A. Kandutsch Correlation between oxysterol binding to a cytosolic binding protein and potency in the repression of hydroxymethylglutaryl coenzyme A reductase J. Biol. Chem 259 1984 12382 12387
39. M. Umetani, H. Domoto, A.K. Gormley, I.S. Yuhanna, C.L. Cummins, N.B. Javitt, and et al. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen Nat. Med 13 2007 1185 1192
40. Wang C., M. Gale Jr., B.C. Keller, Huang H., M.S. Brown, J.L. Goldstein, and et al. Identification of FBL2 as a geranylgeranylated cellular protein required for hepatitis C virus RNA replication Mol. Cell 18 2005 425 434
41. G. Waris, D.J. Felmlee, F. Negro, and A. Siddiqui Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress J. Virol 81 2007 8122 8130
42. Xiang Y., Tang J.J., Tao W., Cao X., Song B.L., and Zhong J. Identification of cholesterol 25-hydroxylase as a novel host restriction factor and a part of the primary innate immune responses against hepatitis C virus infection J. Virol 89 2015 6805 6816
43. Yang W., B.L. Hood, S.L. Chadwick, Liu S., S.C. Watkins, Luo G., and et al. Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production Hepatology 48 2008 1396 1403
44. Ye J., Wang C., R. Sumpter Jr., M.S. Brown, J.L. Goldstein, and M. Gale Jr. Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation Proc. Natl. Acad. Sci. U.S.A. 100 2003 15865 15870